FDA Inspection 1227553 — Triclinic Labs, Inc.
The FDA completed an inspection of Triclinic Labs, Inc. on Jan 17, 2024 in Lafayette, IN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 17, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Lafayette, IN (United States)